Zimmer Partners, LP Evolus, Inc. Transaction History
Zimmer Partners, LP
- $5.03 Billion
- Q3 2024
A detailed history of Zimmer Partners, LP transactions in Evolus, Inc. stock. As of the latest transaction made, Zimmer Partners, LP holds 250,000 shares of EOLS stock, worth $3.53 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
250,000
Previous 501,629
50.16%
Holding current value
$3.53 Million
Previous $5.44 Million
25.58%
% of portfolio
0.08%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding EOLS
# of Institutions
167Shares Held
47.2MCall Options Held
130KPut Options Held
51K-
Perceptive Advisors LLC New York, NY5.36MShares$75.7 Million2.27% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$68.5 Million6.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$56.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$45.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.82MShares$39.9 Million2.72% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $793M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...